Stock Analiz

Janux Therapeutics, Inc. (JANX) stock forecast and price target

Price $11.37 · data as of November 13, 2026

12-month price target

Average target$33.14
Upside / downside+191.5%
Analysts14
ConsensusStrong buy
Low $15.00Average $33.14High $60.00

Gold marker: average target · white marker: today’s price ($11.37)

Analyst ratings

Strong buy 2Buy 13Hold 2Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.57+14.0%$27M
Next fiscal year
ends December 31, 2027
$-2.55−62.1%$6M
Next quarter
ends December 31, 2026
$-0.51−0.2%$4M
Quarter after
ends March 31, 2027
$-0.56−44.6%$2M

Consensus of the analysts covering Janux Therapeutics, updated daily. In the last 30 days 5 estimates were raised and 1 lowered.

Frequently asked questions

What is the Janux Therapeutics stock price target?

The average 12-month target from 14 analysts is $33.14, 191.5% above the current price of $11.37 Targets range from $15.00 to $60.00.

Is Janux Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 13 buy, 2 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Janux Therapeutics expected to earn?

Analysts expect EPS of $-1.57 for the fiscal year ending December 31, 2026 and $-2.55 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.